ANOVA and Tukey test. the role of acrolein in SCI was further validated by the fact that acrolein injection into the spinal cord caused significant SCI-like tissue damage and motor deficits. Taken together, available evidence strongly suggests a critical causal role of acrolein in the pathogenesis of spinal cord trauma. Since acrolein has been linked to a variety of illness and conditions, we believe that acrolein-scavenging steps have the potential to be expanded significantly ensuring a broad impact on human health. Keywords:Aldehyde, oxidative stress, lipid peroxidation, acrolein scavenger == Introduction == A significant portion of damage sustained in spinal cord injuries stems from a delayed secondary biochemical reaction that amplifies the effects of physical insults and spreads additional damage throughout the cord. Oxidative stress, a hallmark of secondary injury, plays a critical role in mediating functional loss in SCI (Hall 1989). However, free radical scavengers have been largely unsuccessful at mitigating secondary injury in the spinal cord. We have recently exhibited that acrolein, an ,-unsaturated aldehyde and a reactive product of lipid peroxidation, is likely a key factor in neural post-traumatic secondary injury (Shi and Luo 2006;Hamann et al. 2008b;Hamann et al. 2008a;Shi et al. 2011a). This is based on its high toxicity to nervous tissue (Picklo and Montine 2001;Shi et al. 2002;Luo and Shi 2004;Luo et al. 2005a;Liu-Snyder et al. 2006b;Shi et al. 2011b), elevated concentrations in SCI (Luo et al. 2005b), and extended presence within biological systems (Esterbauer et al. 1991;Ghilarducci and Tjeerdema 1995;Luo et al. 2005b). Acrolein is usually capable of directly damaging proteins, DNA, and lipids, and stimulating the production of free radicals (Kehrer and Biswal 2000;Stevens and Maier 2008;Shi et al. 2011a). Furthermore, the neurotoxicity of acrolein has been shown to be mediated through poisoning mitochondria, compromising the integrity of neuronal membranes, and degrading myelin (Picklo and Montine 2001;Luo et al. 2005a;Luo and Shi 2005;Hamann et al. 2008a;Shi et al. 2011a;Shi et al. 2011b). Therefore, as both a product of and catalyst for lipid peroxidation (Esterbauer et al. 1991), acrolein appears to induce a vicious cycle of oxidative stress that dramatically amplifies its effects and is likely responsible for continuously propagating degeneration in SCI. Based on existing evidence, we also hypothesize that suppressing acrolein will reduce neuronal damage and enhance functional recovery in SCI. To test such hypothesis, and to further support the active role of acrolein in SCI, we first exhibited that hydralazine, an effective acrolein scavenger, can mitigate acrolein-mediated cell death in PC12 cells (Liu-Snyder et al. 2006a) as well as in isolated spinal cord segment (Hamann et al. 2008a). In addition, hydralazine also prevented acrolein-induced toxicity in cultured hepatocytes (Burcham et al. 2000;Burcham et al. 2004), and hepatoxicity and MS in mice (Kaminskas et al. 2004;Leung et Lesinurad sodium al. 2011). Despite sufficient evidence of neuroprotectionin vitroand the likelihood of a similar effectin vivo, the effect of acrolein scavenging therapy in live animal SCI has not been evaluated. Without this necessary information, the potential value of acrolein as a therapeutic target in the treatment of Lesinurad sodium SCI remains uncertain. The primary goal of this investigation is therefore to ascertain the neuroprotective role of acrolein scavengers in an animal model of SCI, a critical step to further ascertain the role of acrolein in the pathology of SCIin Lesinurad sodium vivo. Such studies were also designed to test the effectiveness of the acrolein scavenger, hydralazine, an FDA-approved hypertensive medication in suppressing acrolein in a live animal model of SCI to reduce secondary injury and promote functional recovery. == Material and methods == == Animal == Male Sprague-Dawley rats weighing 200250 grams at the time of surgery were used. Rats were obtained from Harlan Laboratory (Indianapolis, IN, USA) housed and dealt Lesinurad sodium with in compliance with the Purdue University or college Mouse monoclonal to CD56.COC56 reacts with CD56, a 175-220 kDa Neural Cell Adhesion Molecule (NCAM), expressed on 10-25% of peripheral blood lymphocytes, including all CD16+ NK cells and approximately 5% of CD3+ lymphocytes, referred to as NKT cells. It also is present at brain and neuromuscular junctions, certain LGL leukemias, small cell lung carcinomas, neuronally derived tumors, myeloma and myeloid leukemias. CD56 (NCAM) is involved in neuronal homotypic cell adhesion which is implicated in neural development, and in cell differentiation during embryogenesis Animal Care and Use Committee guidelines and ARRIVE guidelines. The institutional protocol number for this study is usually 1111000276. The animals were kept at.